Evidence map›Paper›PMID 34249455›Full record

ArticleAmerican journal of cancer research2021

Changing trends and disparities in 5-year overall survival of women with invasive breast cancer in the United States, 1975-2015.

Mu Yang, Xin Hu, Wei Bao, Xinmin Zhang, Yong Lin, Sasha Stanton, Bruce Haffty, Wenwei Hu, Yibin Kang, Shi Wei and 1 more

Abstract read
In one paragraph

Article in American journal of cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mu YangDepartment of Pathology, Princeton Medical Center Plainsboro, NJ, USA.
Xin HuYale Center for Analytical Sciences, School of Public Health, Yale University New Haven, CT, USA.
Wei BaoDepartment of Epidemiology, College of Public Health, University of Iowa Iowa City, IA, USA.
Xinmin ZhangDepartment of Pathology, Cooper University Hospital, Cooper Medical School of Rowan University Camden, NJ, USA.
Yong LinRutgers Cancer Institute of New Jersey New Brunswick, NJ, USA.
Sasha StantonCancer Vaccine Institute, University of Washington Seattle, WA, USA.
Bruce HafftyRutgers Cancer Institute of New Jersey New Brunswick, NJ, USA.
Wenwei HuRutgers Cancer Institute of New Jersey New Brunswick, NJ, USA.
Yibin KangDepartment of Molecular Biology, Princeton University Princeton, NJ, USA.
Shi WeiDepartment of Pathology, University of Alabama at Birmingham Birmingham, AL, USA.
Lanjing ZhangDepartment of Pathology, Princeton Medical Center Plainsboro, NJ, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Relative survival is the ratio of overall survival (OS) over survival of the general population, and widely used in epidemiological studies. But it is artificially higher than OS and thus inferior to OS for cancer prognostication of individual patients. Moreover, trend-changes and disparities in OS of breast cancer are unclear while the relative survival of breast cancer has been reported on a regular basis. Therefore, we estimated trends in age-standardized 5-year OS of invasive breast cancer, using data from the Surveillance, Epidemiology, and End Results (SEER) cancer registry program and piecewise-linear regression models. Among 188,052 women with breast cancer diagnosed during 2007-2010 (SEER-18, 155,515 [79.3%] survived by year 5), the 5-year OS significantly differed by age, histology, tumor grade, tumor stage, hormone receptors, race/ethnicity, insurance status, region, rural-urban continuum and selected county-attributes. Among 469,498 women with breast cancer diagnosed during 1975-2010 (SEER-9) in the U.S., we observed an upward trend in the age-standardized 5-year OS (stage- and race/ethnicity-adjusted annual percentage change = 0.97 [95% CI, 0.76-1.18]). The 36-year trends/slopes in age-standardized 5-year OS of breast cancer differed by histology, tumor grade, stage, race/ethnicity, region and socioeconomic attributes of the patient's residence-county, but not by those of rural-urban continuum. The 3-joinpoint model on the 36-year trend identified significant slope changes in 1983, 1987 and 2000, with the largest slope (2.5%/year) during 1983-1987. In conclusion, we here show trends in the age-standardized 5-year OS among U.S. women with breast cancer changed in diagnosis-years of 1983, 1987 and 2000, and differed by tumor characteristics and race/ethnicity. More efforts are needed to understand the trend changes and to address the OS disparities of breast cancers.

Indexed as

Breast cancerdisparityhistologysurvival ratetrends

Identifiers

PMID34249455
PMCPMC8263668

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.